GREY:CLAZF - Post by User
Comment by
PTBaileyon Sep 09, 2021 7:55am
134 Views
Post# 33830051
RE:RE:Covid
RE:RE:Covid Sacloco wrote: LOL...that's very funny Angela, what about the graft versus host disease drug that was gonna revolutionize the industry? Remember it performed better than expected in all three stages and then it was approved for the FDA fast track program? What happened to that? All of a sudden it was dropped for this new covid drug that's gonna revolutionize the industry, funny how this company is able to pivot to the newest issue facing the general public, send out lots of press releases, raise money while the SP tanks and lie to everybody until the newest MARKETING OPPORTUNITY comes along...pharmaceutical companies make medication and drugs, MARKETING COMPANIES make promises and press releases. Kalytera/claritas has not produced any medication or drugs, CAUSE YOUR A MEDICAL MARKETING COMPANY.. LISTEN UP INVESTORS, THIS COMPANY WILL CONTINUE TO MARKET MAKE BELIEVE MEDICATION AND TREATMENT WHILE ACTUALLY PRODUCING NEITHER, THEY WILL ISSUE WARRANTS AND PAY PARTNER COMPANIES WITH SHARES, THEN BORROW MONEY BASED ON THE ELEVATED SP, WHICH IS A RESULT THE SHARE CONSOLIDATION. ONCE SHARES REACH 700-800M AGAIN, GUESS WHAT? CORRECT! ANOTHER SHARE CONSOLIDATION...ROUND AND ROUND WE GO...YOU'VE BEEN WARNED...
There is a lot of information here with no data to support what you are saying. Could you share links to the info you have here such as approval of FDA fast track, all three stages of trials, etc.
This may be helpful for you.
https://claritasinvestors.com/index.php?/topic/1063-putting-the-gvhd-canard-to-bed/&tab=comments#comment-3745